| Fusobacterium nucleatum supresses anti-tumor immunity by activating CEACAM1 C Gur, N Maalouf, A Shhadeh, O Berhani, BB Singer, G Bachrach, ... Oncoimmunology 8 (6), e1581531, 2019 | 116 | 2019 |
| NK cell recognition of Candida glabrata through binding of NKp46 and NCR1 to fungal ligands Epa1, Epa6, and Epa7 A Vitenshtein, Y Charpak-Amikam, R Yamin, Y Bauman, B Isaacson, ... Cell host & microbe 20 (4), 527-534, 2016 | 87 | 2016 |
| High percentages and activity of synovial fluid NK cells present in patients with advanced stage active Rheumatoid Arthritis R Yamin, O Berhani, H Peleg, S Aamar, N Stein, M Gamliel, I Hindi, ... Scientific reports 9 (1), 1-12, 2019 | 67 | 2019 |
| HNRNPR regulates the expression of classical and nonclassical MHC class I proteins A Reches, D Nachmani, O Berhani, A Duev-Cohen, D Shreibman, Y Ophir, ... The Journal of Immunology 196 (12), 4967-4976, 2016 | 48 | 2016 |
| The RNA binding protein IMP3 facilitates tumor immune escape by downregulating the stress-induced ligands ULPB2 and MICB D Schmiedel, J Tai, R Yamin, O Berhani, Y Bauman, O Mandelboim Elife 5, e13426, 2016 | 47 | 2016 |
| The human 2B4 and NTB-A receptors bind the influenza viral hemagglutinin and co-stimulate NK cell cytotoxicity A Duev-Cohen, Y Bar-On, A Glasner, O Berhani, Y Ophir, F Levi-Schaffer, ... Oncotarget 7 (11), 13093, 2016 | 44 | 2016 |
| IFNG-AS1 enhances interferon gamma production in human natural killer cells N Stein, O Berhani, D Schmiedel, A Duev-Cohen, E Seidel, I Kol, ... Iscience 11, 466-473, 2019 | 42 | 2019 |
| Transcription of the NKG2D ligand MICA is suppressed by the IRE1/XBP1 pathway of the unfolded protein response through the regulation of E2F1 A Obiedat, E Seidel, M Mahameed, O Bernani, P Tsukerman, K Voutetakis, ... The FASEB Journal 33 (3), 3481-3495, 2019 | 34 | 2019 |
| Fusobacterium nucleatum CbpF Mediates Inhibition of T Cell Function Through CEACAM1 Activation J Galaski, A Shhadeh, A Umaña, CC Yoo, L Arpinati, B Isaacson, ... Frontiers in Cellular and Infection Microbiology 11, 692544, 2021 | 22 | 2021 |
| Expression, function, and molecular properties of the killer receptor Ncr1-Noe A Glasner, H Simic, K Miklić, Z Roth, O Berhani, I Khalaila, S Jonjic, ... The Journal of Immunology 195 (8), 3959-3969, 2015 | 18 | 2015 |
| SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection AE Chaouat, H Achdout, I Kol, O Berhani, G Roi, EB Vitner, S Melamed, ... PLoS Pathogens 17 (12), e1010175, 2021 | 17 | 2021 |
| Human anti‐NKp46 antibody for studies of NKp46‐dependent NK cell function and its applications for type 1 diabetes and cancer research O Berhani, A Glasner, S Kahlon, A Duev‐Cohen, R Yamin, E Horwitz, ... European journal of immunology 49 (2), 228-241, 2019 | 17 | 2019 |
| A unique regulation region in the 3′ UTR of HLA-G with a promising potential A Reches, O Berhani, O Mandelboim International Journal of Molecular Sciences 21 (3), 900, 2020 | 14 | 2020 |
| Vigilin regulates the expression of the stress-induced ligand MICB by interacting with its 5′ untranslated region O Berhani, D Nachmani, R Yamin, D Schmiedel, Y Bar-On, O Mandelboim The Journal of Immunology 198 (9), 3662-3670, 2017 | 11 | 2017 |
| Altered NKp46 recognition and elimination of influenza b viruses A Duev-Cohen, B Isaacson, O Berhani, Y Charpak-Amikam, N Friedman, ... Viruses 13 (1), 34, 2020 | 5 | 2020 |
| Eradication of CD48-positive tumors by selectively enhanced YTS cells harnessing the lncRNA NeST R Kotzur, N Stein, S Kahlon, O Berhani, B Isaacson, O Mandelboim Iscience 26 (8), 2023 | | 2023 |
| Antibodies to nkp46 and constructs thereof for treatment of cancers and infections S Jonjic, O Mandelboim, O Berhani, S Kahalon US Patent App. 17/995,651, 2023 | | 2023 |
| SARS-CoV-2 receptor binding domain fusion protein efficiently neutralizes virus infection (preprint) AE Chaouat, H Achdout, I Kol, O Berhani, G Roi, EB Vitner, S Melamed, ... | | 2021 |
| Anti-NKP46 antibodies, toxin conjugates, and therapeutic use of same O Mandelboim, S Jonjic, O Berhani, A Glasner US Patent 10,716,864, 2020 | | 2020 |
| Altered NKp46 Recognition and Elimination of Influenza B Viruses. Viruses 2021, 13, 34 A Duev-Cohen, B Isaacson, O Berhani, Y Charpak-Amikam, N Friedman, ... s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2020 | | 2020 |
Yoav Charpak-AmikamM.D./Ph.D. student, Hebrew University of JerusalemVerified email at mail.huji.ac.il
